View or download a list of frequently asked questions about treatment options for non–small cell lung cancer (NSCLC) and the importance of biomarker testing.
View or download a list of questions to ask your health care team about an NSCLC diagnosis and how biomarker testing can help inform treatment options.
Additional Resources
The LUNGevity Foundation is dedicated to funding lung cancer research and providing education and support to people living with lung cancer. The foundation also hosts an extensive online community for patients and caregivers.
GO2 Foundation for Lung Cancer
The GO2 Foundation for Lung Cancer is dedicated to saving, improving, and extending the lives of people at risk for or living with lung cancer. It provides free patient support services, advances patient-centric research, and works to expand screening, care, treatment, and survivorship.
The Lung Cancer Research Foundation
The Lung Cancer Research Foundation is an organization focused on improving lung cancer outcomes through awareness and education, as well as funding research for the prevention, diagnosis, treatment, and cure of lung cancer.
Genentech does not control or endorse the content of the third-party websites listed here, and Genentech makes no representation as to the accuracy of the information contained on these websites. The information provided by these organizations is meant for informational purposes only and is not meant to replace a doctor’s medical advice. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.
-
Non–small cell lung cancer (NSCLC)
The most common form of lung cancer, which is described by the way the cancer cells look under a microscope (not small).
-
Targeted Therapy
A treatment that targets the driver mutations that cause cancer growth.